Citations 1
ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R2‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma
Gascoyne, Randy D. , Zhang, Q. , Móciková, Heidi , Molinari, Anna Lia, Yoon, Dok Hyun , Tani, Monica , Kato, Koji , Czuczman, M. S., Hersey, S. J., Kilcoyne, Adrian , Russo, Jacqueline, Hudak, Krista, Zhang, J., Nowakowski, Grzegorz S. , investigators, on behalf of the ROBUST study, Vitolo, Umberto , Witzig, Thomas E. , Scott, David W. , Jurczak, Wojciech , Özcan, Muhıt , Hong, X., Zhu, Jun , Jin, Jie , Belada, David , Bergua, Juan , Piazza, Francesco , Cavallo, Federica , Izutsu, Koji , Hersey, S., Chiappella, Annalisa , investigators, on behalf of the ROBUST study
Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 36-37
